HPV and precancerous lesions of the cervix
prev Tooltip
Skin cancer and Photocure technology®

Skin cancer and Photocure technology®

We have developed, registered and divested a product for skin cancer lesions, based on our unique Photocure Technology®, which removes only affected tissue, while leaving normal tissue unharmed.
Bladder Cancer
next Tooltip
This information is for healthcare professionals only

Main content

Metvix® - for the treatment of non-melanoma skin cancer

Our product Metvix® and the light source Aktilite® was launched in the Nordics in 2001. Later in the US and rest of the world. In 2009 these two products were divested to Galderma, who now retains all the rights for these products.

For more information about this product, please go to www.galderma.com